NEW YORK (TheStreet) — CHANGE IN RATINGS
Chubb (CB) upgraded at S&P from Hold to Buy, Standard & Poors said. $80 price target. Company trades at a discount to its peers. DSW (DSW) rated new Buy at Brean Murray. $65 price target. Recent pullback has created an attractive buying opportunity. Facebook (FB) rated new Neutral at Citigroup. $35 price target. Significant long term potential offset by medium term risk. Facebook rated new Overweight at Morgan Stanley. $38 price target. Company can leverage its user base and monetize the mobile Internet. Facebook rated new Neutral at Credit Suisse. Valuation call, based on a $34 price target. Facebook rated new Buy at Goldman Sachs. $42 price target. Social media is ushering in the next era of the web and the company can dominate this. Facebook rated new Overweight at JP Morgan. $45 price target. Ad platform is growing stronger and the company should be able to monetize the mobile market. Facebook rated new Neutral at BofA/Merrill. $38 price target. Cautious on near-term sales trends. Hasbro (HAS) downgraded at Citigroup to Sell from Neutral, Citigroup said. $31 price target. Core businesses are largely underperforming. Heartland Payment (HPY) upgraded at KBW from Market Perform to Outperform. Valuation call, based on a $34 price target. Nordstrom (JWN) downgraded at Citigroup to Neutral from Buy, Citigroup said. $52 price target. Cautious 2H outlook. Macy’s (M) downgraded at Citigroup to Neutral from Buy, Citigroup said. $37 price target. Unlikely to be star performer in 2H12. Nvidia (NVDA) upgraded at S&P from Hold to Buy, Standard & Poors said. Sales of the new Tegra 3 processor should begin to ramp in the second half of the year. News Corp. (NWSA) upgraded at Needham from Hold to Buy, Needham said. $27 price target. Spin-off could create more than $5 a share of value. Riverbed Technology (RVBD) upgraded at Jefferies to Hold from Underweight, Jefferies said. $14 price target. Risk/reward now evenly balanced. Saks (SKS) downgraded at Citigroup to Neutral from Buy, Citigroup said. $11 price target. Stepping to sidelines as high end strength fades.